TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Clinical Investigation

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14523048PMCID PMC198530
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Malignant MCF10CA1 Cell Lines Derived from Premalignant Human Breast Epithelial MCF10AT Cells

  2004cited by this paper
• Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.

  2003cited by this paper
• TGF-beta signaling: positive and negative effects on tumorigenesis.

  2002cited by this paper
• Conditional loss of TGF‐β signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice

  2002cited by this paper
• Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

  2002cited by this paper
• Rapamycin Potentiates Transforming Growth Factor β-Induced Growth Arrest in Nontransformed, Oncogene-Transformed, and Human Cancer Cells

  2002cited by this paper
• TGF-beta signaling in tumor suppression and cancer progression.

  2001cited by this paper
• Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis

  2001cited by this paper
• MS-275, a histone deacetylase inhibitor, selectively induces transforming growth factor beta type II receptor expression in human breast cancer cells.

  2001cited by this paper
• Putting tumours in context

  2001cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• The Role of Sp1 in the Differential Expression of Transforming Growth Factor-β Receptor Type II in Human Breast Adenocarcinoma MCF-7 Cells*

  2000cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000cited by this paper
• Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in‐situ and invasive carcinomas

  2000cited by this paper
• The role for transforming growth factor-beta (TGF-beta) in human cancer.

  1999cited by this paper
• Transforming growth factor-beta and breast cancer risk in women with mammary epithelial hyperplasia.

  1999cited by this paper
• Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.

  1999cited by this paper
• Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development

  1998cited by this paper
• TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis.

  1998cited by this paper
• Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.

  1997cited by this paper
• MCF10AT: a model for the evolution of cancer from proliferative breast disease.

  1996cited by this paper
• Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor

  1995cited by this paper
• Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.

  1993cited by this paper
• Resistance to inhibition of cell growth by transforming growth factor-beta and its role in oncogenesis.

  1993cited by this paper
• Production of high-titer helper-free retroviruses by transient transfection.

  1993cited by this paper
• Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.

  1992cited by this paper
• Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

  1992cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Loss of growth factor dependence and conversion of transforming growth factor-beta 1 inhibition to stimulation in metastatic H-ras-transformed murine fibroblasts.

  1988cited by this paper

• SLPI in Prostate Cancer

  2026cites this paper
• Prominent protumoral cellular compartments of the tumor microenvironment in triple-negative breast cancer

  2026cites this paper
• The “double-edged sword” effect of cytokines in cancer: coexisting opportunities and challenges

  2025cites this paper
• C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer

  2024cites this paper
• TGF-β signaling in health, disease and therapeutics

  2024cites this paper
• Predictive Biomarkers for Response to TGF- β Inhibition in Resensitizing Chemo(radiated) Esophageal Adenocarcinoma.

  2024cites this paper
• TGFβ in malignant canine mammary tumors: relation with angiogenesis, immunologic markers and prognostic role

  2024cites this paper
• Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer

  2024cites this paper
• Mutations involving TGFB and MAPK may be associated with malignancy in granular cell tumors

  2023cites this paper
• An updated review on distribution, biosynthesis and pharmacological effects of artemisinin: A wonder drug.

  2023cites this paper
• Small Leucine-Rich Proteoglycan PODNL1 Identified as a Potential Tumor Matrix-Mediated Biomarker for Prognosis and Immunotherapy in a Pan-Cancer Setting

  2023cites this paper
• Extracellular matrix viscoelasticity regulates TGFβ1‐induced epithelial‐mesenchymal transition and apoptosis via integrin linked kinase

  2023cites this paper
• Understanding AKT-mediated chemoresistance: the relationship between ion channels and AKT activation

  2023cites this paper
• Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

  2023cites this paper
• Dynamics of transforming growth factor β signaling and therapeutic efficacy

  2023cites this paper
• Role of long non-coding RNAs and TGF-β signaling in the regulation of breast cancer pathogenesis and therapeutic targets.

  2023cites this paper
• A MYC-ZNF148-ID1/3 regulatory axis modulating cancer stem cell traits in aggressive breast cancer

  2022cites this paper
• New roles for AP-1/JUNB in cell cycle control and tumorigenic cell invasion via regulation of cyclin E1 and TGF-β2

  2022cites this paper
• PLXND1/SEMA3E Promotes Epithelial–Mesenchymal Transition Partly via the PI3K/AKT-Signaling Pathway and Induces Heterogenity in Colorectal Cancer

  2022cites this paper
• Inflammatory Breast Cancer: The Secretome of HCMV+ Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers

  2022cites this paper
• Supervillin reorganizes the actin cytoskeleton and increases Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency invadopodial efficiency Let us know how access to this document benefits you.

  2022cites this paper
• Oncogenic Pathways in Neurodegenerative Diseases

  2022cites this paper
• Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment

  2021cites this paper
• Image-based high-throughput mapping of TGF-β-induced phosphocomplexes at a single-cell level

  2021cites this paper
• The Multifaceted Role of TGF-β in Gastrointestinal Tumors

  2021cites this paper
• N-cadherin mediates the migration of bone marrow-derived mesenchymal stem cells toward breast tumor cells

  2021cites this paper
• Therapeutically Targeting Cancers That Overexpress FOXC1: A Transcriptional Driver of Cell Plasticity, Partial EMT, and Cancer Metastasis

  2021cites this paper
• Spontaneous formation and spatial self-organization of mechanically induced mesenchymal-like cells within geometrically confined cancer cell monolayers.

  2021cites this paper
• Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

  2021cites this paper
• Positive Association of Matrix Proteins Alteration with TAZ and The Progression of High-Grade Bladder Cancer

  2021cites this paper
• Proliferation‐associated long noncoding RNA, TMPO‐AS1, is a potential therapeutic target for triple‐negative breast cancer

  2020cites this paper
• Functional role of WW domain‐containing proteins in tumor biology and diseases: Insight into the role in ubiquitin‐proteasome system

  2020cites this paper
• Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors

  2020cites this paper
• OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer

  2020cites this paper
• Antisense Oligonucleotide in LNA-Gapmer Design Targeting TGFBR2—A Key Single Gene Target for Safe and Effective Inhibition of TGFβ Signaling

  2020cites this paper
• Role of fibrillin-2 in the control of TGF-β activation in tumor angiogenesis and connective tissue disorders.

  2020cites this paper
• Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis

  2019cites this paper
• Current status and future prospects of transforming growth factor‐β as a potential prognostic and therapeutic target in the treatment of breast cancer

  2019cites this paper
• Pharmacology Study of the Multiple Angiogenesis Inhibitor RC28-E on Anti-Fibrosis in a Chemically Induced Lung Injury Model

  2019cites this paper
• A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue

  2019cites this paper
• Multiple actions of parathyroid hormone‐related protein in breast cancer bone metastasis

  2019cites this paper
• Functional Role of miRNAs in the Progression of Breast Ductal Carcinoma in Situ.

  2019cites this paper
• Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

  2019cites this paper
• Actin Cytoskeleton and Focal Adhesions Regulate the Biased Migration of Breast Cancer Cells on Nanoscale Asymmetric Sawteeth.

  2019cites this paper
• Corilagin in Cancer: A Critical Evaluation of Anticancer Activities and Molecular Mechanisms

  2019cites this paper
• Association Between Head and Neck Cancers and Polymorphisms 869T/C, 509C/T, and 915G/C of the Transforming Growth Factor-β1 Gene: A Meta-Analysis of Case-Control Studies

  2019cites this paper
• Dual role of TGF-β in early pregnancy: clues from tumor progression

  2019cites this paper
• Artemisinin enhances the anti‐tumor immune response in 4T1 breast cancer cells in vitro and in vivo

  2019cites this paper
• GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients

  2019cites this paper
• WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

  2019cites this paper
• T Regulatory Cells and Priming the Suppressive Tumor Microenvironment

  2019cites this paper
• LncRNA-mediated regulation of SOX9 expression in basal subtype breast cancer cells

  2019cites this paper
• A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity

  2019influential citation
• Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer.

  2019cites this paper
• The Long (lncRNA) and Short (miRNA) of It: TGFβ-Mediated Control of RNA-Binding Proteins and Noncoding RNAs

  2018cites this paper
• Lysophosphatidic acid regulates the motility of MCF10CA1a breast cancer cell sheets via two opposing signaling pathways.

  2018cites this paper
• Semaphorin 4D in human head and neck cancer tissue and peripheral blood: A dense fibrotic peri-tumoral stromal phenotype

  2018cites this paper
• A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability

  2018cites this paper
• Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis

  2018cites this paper
• Palbociclib enhances activin‐SMAD‐induced cytostasis in estrogen receptor‐positive breast cancer

  2018cites this paper
• Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer

  2018cites this paper
• TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

  2018cites this paper
• Genetic Modifiers of the Breast Tumor Microenvironment.

  2018cites this paper
• FIBRONECTIN MECHANICS AND SIGNALING IN TGF-β1-INDUCED EPITHELIAL TO MESENCHYMAL TRANSITION

  2018cites this paper
• The concomitant apoptosis and EMT underlie the fundamental functions of TGF-β.

  2018cites this paper
• Profiles of Radioresistance Mechanisms in Prostate Cancer.

  2018cites this paper
• Human cytomegalovirus glycoprotein B inhibits migration of breast cancer MDA-MB-231 cells and impairs TGF-β/Smad2/3 expression

  2018cites this paper
• KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.

  2018cites this paper
• Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells.

  2017cites this paper
• The transcription factor MAFK induces EMT and malignant progression of triple-negative breast cancer cells through its target GPNMB

  2017cites this paper
• Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease.

  2017cites this paper
• RNA‐editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA

  2017cites this paper
• Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells

  2017cites this paper
• Stromal Modulators of TGF-β in Cancer

  2017cites this paper
• Using the Dot Assay to Analyze Migration of Cell Sheets.

  2017cites this paper
• Effect of NIMA-related kinase 2B on the sensitivity of breast cancer to paclitaxel in vitro and vivo

  2017cites this paper
• Association between TGF-β1 Polymorphisms and Head and Neck Cancer Risk: A Meta-Analysis

  2017cites this paper
• MicroRNAs in Oncogenesis and Tumor Suppression.

  2017cites this paper
• The biological and clinical significance of stromal-epithelial interactions in breast cancer.

  2017cites this paper
• Causes and consequences of nuclear envelope alterations in tumour progression.

  2016cites this paper
• MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3

  2016cites this paper
• Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer

  2016cites this paper
• How Little Is Too Much? – How Transient Tumor-Stromal Crosstalk Can Control Tumor Progression

  2016cites this paper
• MYC Is a Crucial Mediator of TGFβ-Induced Invasion in Basal Breast Cancer.

  2016cites this paper
• F344/NTac Rats Chronically Exposed to Bromodichloroacetic Acid Develop Mammary Adenocarcinomas With Mixed Luminal/Basal Phenotype and Tgfβ Dysregulation

  2016cites this paper
• MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway

  2016cites this paper
• Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma

  2016cites this paper
• MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer

  2016influential citation
• TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.

  2016cites this paper
• Adaptive metabolic rewiring to chronic SFK inhibition

  2016cites this paper
• TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis

  2015cites this paper
• Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.

  2015cites this paper
• Proteomic profiling identifies specific histone species associated with leukemic and cancer cells

  2015cites this paper
• Selective blockade of cancer cell proliferation and anchorage-independent growth by Plk1 activity–dependent suicidal inhibition of its polo-box domain

  2015cites this paper
• Fibulin-3 is a Novel TGF-β pathway Inhibitor in the Breast Cancer Microenvironment

  2015cites this paper
• Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

  2015cites this paper
• Induction of Epithelial-Mesenchymal Transition (EMT) in women´s cancer : protective role of differentiation factors

  2015cites this paper
• MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC

  2015cites this paper
• Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: Prognostic and predictive markers in triple-negative and non-triple-negative breast cancer

  2015cites this paper
• Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta role.

  2015cites this paper